ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 DiabetesMichael Brines, Albert Dahan, Ann Dunne et al.|Molecular Medicine|2014Cited by 143
Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot StudyLara R. Heij, Albert Dahan, Marieke Niesters et al.|Molecular Medicine|2012Cited by 110
Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic PainDaniel A. Culver, Michael Brines, Ioannis N. Petropoulos et al.|Investigative Ophthalmology & Visual Science|2017Cited by 103
ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber DensityAlbert Dahan, Michael Brines, Ann Dunne et al.|Molecular Medicine|2013Cited by 94
ARA 290 for treatment of small fiber neuropathy in sarcoidosisMonique van Velzen, Michael Brines, Lara R. Heij et al.|Expert Opinion on Investigational Drugs|2014Cited by 40